Genomic organization and expression of Tpl-2 in normal cells and Moloney murine leukemia virus-induced rat T-cell lymphomas: activation by provirus insertion - PubMed (original) (raw)

Genomic organization and expression of Tpl-2 in normal cells and Moloney murine leukemia virus-induced rat T-cell lymphomas: activation by provirus insertion

A Makris et al. J Virol. 1993 Jul.

Abstract

Tpl-2 is a gene encoding a protein kinase which is primarily expressed in normal spleen, thymus, and lung tissue and is activated by provirus insertion in Moloney murine leukemia virus-induced T-cell lymphomas during the late stages of oncogenesis. Tpl-2 is composed of eight exons and spans a 35-kb genomic DNA region. The provirus integrates reproducibly in the last intron and in the same transcriptional orientation as the Tpl-2 gene. This genetic change leads to the expression of enhanced steady-state levels of a truncated Tpl-2 RNA transcript which is predicted to encode a protein with an altered C-terminal domain. Tpl-2 is transcribed from two alternating promoters, P1 and P2. The RNA transcripts originating in the two promoters harbor different 5' untranslated regions derived from the alternate noncoding exons IA and IB. Utilization of the P2 promoter, which gives rise to exon IB containing Tpl-2 RNA transcripts, was detected primarily in tumor cells. The Tpl-2 protein was expressed in COS-1 cells as an N-terminal fusion with a 12-amino-acid hemagglutinin tag. Immunoprecipitation of transfected COS-1 cell lysates with antihemagglutinin or anti-Tpl-2 antibodies, followed by incubation with [gamma-32P]ATP, confirmed that Tpl-2 possesses protein kinase activity.

PubMed Disclaimer

Cited by

Mutational activation of the MAP3K8 protooncogene in lung cancer.
Clark AM, Reynolds SH, Anderson M, Wiest JS. Clark AM, et al. Genes Chromosomes Cancer. 2004 Oct;41(2):99-108. doi: 10.1002/gcc.20069. Genes Chromosomes Cancer. 2004. PMID: 15287022 Free PMC article.
Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells.
Tsatsanis C, Vaporidi K, Zacharioudaki V, Androulidaki A, Sykulev Y, Margioris AN, Tsichlis PN. Tsatsanis C, et al. Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2987-92. doi: 10.1073/pnas.0708381104. Epub 2008 Feb 19. Proc Natl Acad Sci U S A. 2008. PMID: 18287049 Free PMC article.
Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase.
Gantke T, Sriskantharajah S, Ley SC. Gantke T, et al. Cell Res. 2011 Jan;21(1):131-45. doi: 10.1038/cr.2010.173. Epub 2010 Dec 7. Cell Res. 2011. PMID: 21135874 Free PMC article. Review.
Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer.
Lee HW, Choi HY, Joo KM, Nam DH. Lee HW, et al. Int J Mol Sci. 2015 Feb 25;16(3):4471-91. doi: 10.3390/ijms16034471. Int J Mol Sci. 2015. PMID: 25723737 Free PMC article. Review.
MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen-activated protein kinase 8.
Zhang N, Lin JK, Chen J, Liu XF, Liu JL, Luo HS, Li YQ, Cui S. Zhang N, et al. J Biol Chem. 2013 Apr 12;288(15):10361-73. doi: 10.1074/jbc.M112.425504. Epub 2013 Feb 21. J Biol Chem. 2013. PMID: 23430746 Free PMC article.

References

1. J Natl Cancer Inst. 1968 Aug;41(2):351-7 - PubMed
1. Genomics. 1992 Aug;13(4):1281-8 - PubMed
1. Proc Natl Acad Sci U S A. 1986 May;83(9):2850-4 - PubMed
1. Anal Biochem. 1987 Apr;162(1):156-9 - PubMed
1. Mol Cell Biol. 1988 Jan;8(1):284-92 - PubMed

Genomic organization and expression of Tpl-2 in normal cells and Moloney murine leukemia virus-induced rat T-cell lymphomas: activation by provirus insertion - PubMed (original) (raw)